VIONA PHARMACEUTICALS INC recalls Dapsone Gel 7.5%
- Published
- 8 Jan 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Crystallization
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack
Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack
- Brand / company
- VIONA PHARMACEUTICALS INC
- Codes / lots
- Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026 | Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.
- Distribution
- US Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 8 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.